The BOREAS Phase III trial showed DUPIXENT reduced exacerbations by 30% and improved lung function by 160 mL at 52 weeks.

What's causing yields to rise? Tariff expectations or tax cuts? Federal Reserve's roadmap to manage inflation and growth The ...

Developed with Market Vector Indexes, COIN50 excludes stablecoins, rebalances quarterly, and meets strict compliance and ...

The idea came right after the two giants of basketball faced off in the 1995 NBA Finals. Hakeem Olajuwon and his Houston ...

LYNN MOORE JR, President and CEO at Tyler Technologies TYL, reported an insider sell on November 12, according to a new SEC ...

Rohit Kapoor, Chairman & CEO at ExlService Holdings EXLS, disclosed an insider sell on November 12, according to a recent SEC ...

Analysts expect Workhorse Gr to report an earnings per share (EPS) of $-1.20. The announcement from Workhorse Gr is eagerly ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

The fast-casual chain, known for its Mediterranean-inspired cuisine, reported earnings of 15 cents per share, surpassing the ...

Persistent speculation about President-elect Donald Trump establishing a national Bitcoin (CRYPTO: BTC) reserve has increased ...

On CNBC's "Halftime Report Final Trades," Bill Baruch picked Microsoft, expecting it to outperform the Nasda qby the end of ...

Coinbase's CEO Armstrong believes in economic freedom and standing up against bad government. They see the recent US election ...